2篇
您的检索式：作者名="Linqian Peng"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension显示文摘Excessive oxidative stress is a major causative factor of endothelial dysfunction in hypertension.As an endogenous pro-oxidant,thioredoxin-interacting protein(TXNIP)contributes to oxidative damage in various tissues.The present study aimed to investigate the role of TXNIP in mediating endothelial dysfunction in hypertension.In vivo,an experimental model of acquired hypertension was established with two-kidney,one-clip(2K1C)surgery.The expression of TXNIP in the vascular endothelial cells of multiple vessels was significantly increased in hypertensive rats compared with sham-operated rats.Resveratrol,a TXNIP inhibitor,suppressed vascular oxidative damage and increased the expression and activity of eNOS in the aorta of hypertensive rats.Notably,impaired endothelium-dependent vasodilation was effectively improved by TXNIP inhibition in hypertensive rats.In vitro,we observed that Ang II increased the expression of TXNIP in primary human aortic endothelial cells(HAECs)and that TXNIP knockdown by RNA interference alleviated cellular oxidative stress damage and mitigated the impaired eNOS activation and intracellular nitric oxide(NO)production observed in Ang Il-treated HAECs.However,inhibiting thioredoxin(TRX)with PX-12 completely blunted the protective effect of silencing TXNIP.In addition,TXNIP knockdown facilitated TRX expression and promoted TRX nuclear translocation to further activate AP1 and REF1.TRX overexpressi on exhibited favorable effects on eNOS/NO homeostasis in Ang 11-treated HAECs.Thus,TXNIP contributes to oxidative stress and endothelial dysfunction in hypertension,and these effects are dependent on the antioxidant capacity of TRX,suggesting that targeting TXNIP may be a novel strategy for antihypertensive therapy. | Ruiyu Wang Yongzheng Guo Lingjiao Li Minghao Luo Linqian Peng Dingyi Lv Zhe Cheng Qian Xue Liang Wang Jing Huang | 2022 | Genes & Diseases2022，9，3： | 1 |
| 2 | Anti-tumor Effect of Paclitaxel Enhanced by Psoralen at the Cellular Level显示文摘[Objectives]To explore the effect of psoralen combined with paclitaxel on the apoptosis of MCF-7 cells.[Methods]The effects of different concentrations of psoralen,paclitaxel,or the combination of psoralen and paclitaxel on cell viability were detected using CCK-8 assay kit.Cell cycle distribution and apoptosis after 24 h of psoralen(0.16,0.32,0.64 mmol/L),paclitaxel(0.1μmol/L),combined action of psoralen(0.32 mmol/L)and paclitaxel(0.1μmol/L)were detected using flow cytometry.[Results]Lower concentration of psoralen(0.04-0.32 mmol/L)showed no significant inhibitory effect on cells.After combined with paclitaxel,the inhibitory effect on MCF-7 cell proliferation was significantly higher than that of the group treated alone.Compared with the paclitaxel group,the cell apoptosis rate in the drug combination group was significantly increased.Different low concentrations of psoralen can block the cell cycle of MCF-7 at G 0/G 1 phase,while paclitaxel can block the cell cycle at G 2/M phase.After combined action,the number of cells blocked at G 2/M phase decreased.[Conclusions]Overall,the combined effect of psoralen and paclitaxel can enhance anti-tumor ability by inhibiting cell proliferation,inducing apoptosis,and blocking cell cycle. | Yinghong HUANG Linqian CHEN Yaping WU Xian PENG Xuemei FANG Chunye LU Jiangcun WEI | 2023 | Medicinal Plant2023，14，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员